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Abstract
Corynebacterium diphtheriae (Cd) is a Gram-positive human pathogen responsible for diphtheria infection and once regarded for high mortalities worldwide. The fatality gradually
decreased with improved living standards and further alleviated when many immunization
programs were introduced. However, numerous drug-resistant strains emerged recently
that consequently decreased the efficacy of current therapeutics and vaccines, thereby
obliging the scientific community to start investigating new therapeutic targets in pathogenic
microorganisms. In this study, our contributions include the prediction of modelome of 13 C.
diphtheriae strains, using the MHOLline workflow. A set of 463 conserved proteins were
identified by combining the results of pangenomics based core-genome and core-modelome analyses. Further, using subtractive proteomics and modelomics approaches for target identification, a set of 23 proteins was selected as essential for the bacteria. Considering
human as a host, eight of these proteins (glpX, nusB, rpsH, hisE, smpB, bioB, DIP1084, and
DIP0983) were considered as essential and non-host homologs, and have been subjected
to virtual screening using four different compound libraries (extracted from the ZINC database, plant-derived natural compounds and Di-terpenoid Iso-steviol derivatives). The proposed ligand molecules showed favorable interactions, lowered energy values and high
complementarity with the predicted targets. Our proposed approach expedites the selection
of C. diphtheriae putative proteins for broad-spectrum development of novel drugs and vaccines, owing to the fact that some of these targets have already been identified and validated
in other organisms.
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Introduction
Corynebacterium diphtheriae is responsible for causing diphtheria which remains a major
global cause of death (http://www.who.int/immunization_monitoring/diseases/diphteria/),
and has conventionally been divided into four subgroups of biovars i.e., gravis, intermedius,
mitis and belfanti based on biochemical characteristics according to Funke et al., 1997 [1] and
Whitman et al., 2012 [2]. It was once a major cause of infant mortality, which spread as an epidemic and resulted in thousands of deaths [3]. The death rates dropped over time specifically
in countries where living standards have improved, and the death rates rapidly declined after
the introduction of immunization programs [3]. Despite these measures, it remains a significant pathogen around the globe, even today. A variety of mechanisms were responsible for
causing such death rates; for example the ‘strangling angel’ effect on children that ascended
from the wing shaped pseudo-membranes formed in the oropharynx. Disarticulation and
impaction of these pseudo-membranes triggers acute airway obstruction and can result in sudden death [3, 4]. Since there has been a plethora of reported cases on both non-lethal and lethal
diphtheria across various countries in the past few years, and that significant population displacements in the form of immigration are happening, more such cases are bound to follow. A
passable handling requires quick inroads in discovering diphtheria antitoxin and antibiotic
treatment [5].
Computational methods and other approaches, like reverse vaccinology, have been established for the rapid identification of novel targets in the post-genomic era [6, 7]. Approaches
like subtractive and comparative microbial genomics as well as differential genome analysis [8]
are being used for the identification of targets in a number of human pathogens like M. tuberculosis [9], Burkholderia pseudomalleii [10], Helicobacter pylori [11] Pseudomonas aeruginosa
[12], Neisseria gonorrhea [13] and Salmonella typhi [14].
The main principle is to find targeted genes/proteins that are essential for the pathogen
and possess no homology counterpart in the host [15], such that drugs targeting these
“pathogen-essential non-host homologs” can be applied with little (or no) off targets in the
host. Some pathogen-essential proteins, though, may possess a certain degree of homology
to host proteins. However, they might still be selected as potential molecular targets for
structure-based selective inhibitor development. Significant differences in the active sites or
in other druggable pockets might exist, such that the pathogenic protein could still be targeted [16, 17].
Here, we exploit an integrative in silico approach for the predictive proteome of C.
diphtheriae species to associate the genomic information with the identification of putative
therapeutic targets based on their three dimensional structure. It can be utilized for the
identification of potent inhibitors, which might possibly lead to the discovery of compounds that inhibit pathogenic growth. The predicted proteomes from the 13 genomes of
C. diphtheriae were modeled (pan-modelome) using the MHOLline workflow as proposed
by Hassan et al., 2014 [18]. Furthermore, intra-species conserved proteins with adequate
3D models (core-modelome) were filtered on the basis of predicted essentiality for the bacteria, which leads to the identification of eight essential bacterial proteins. They were found
non homologous to all host proteins and have been subjected to virtual screening using
multiple compound libraries.
We provided a list of putative targets in C. diphteriae, and possible mechanisms to design
peptide vaccines, and suggest novel lead, natural and drug-like compounds that could bind to
the proposed target proteins.
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Materials and methods
Genomes selection
The thirteen C. diphtheriae strains, including three of the four biovars: gravis, mitis and belfanti (Table 1) were included in this study. The gene and protein sequences of these thirteen
C. diphtheriae strains were retrieved from NCBI (ftp://ftp.ncbi.nih.gov/genomes/Bacteria).
The different steps involved in this computational approach for genome-scale modelome prediction and for the prioritization of putative drug and vaccine targets are given in (Figs 1 & 2).

Prediction of core-modelome and identification of core genome
To construct the core-modelome of C. diphtheriae, we followed a slightly modified protocol
described by Hassan et al., 2014 [18]. High throughput structural modeling, MHOLline
(http://www.mholline.lncc.br), was used to predict the modelome (whole-proteome set of protein 3D models) for each strain. MHOLline uses comparative modeling approach for protein
3D structure prediction through MODELLER [19]. Our workflow also includes BLASTp
(Basic Local Alignment Search Tool for Protein) [20], HMMTOP (Prediction of transmembrane helices and topology of proteins), [21] BATS (Blast Automatic Targeting for Structures),
FILTERS, ECNGet (Get Enzyme Commission Number), MODELLER, and PROCHECK [22].
MHOLline work on the basis of available template. It is probable that MHOLline cannot
detect all the common conserved proteins due to the unavailability of the template. To overcome this probability, we used EDGAR (an Efficient Database framework for comparative
Genome Analyses using BLAST score Ratios for pan-genomics analysis) to collect common
conserved genome as well of all Cd strains [23]. Later, the results from MHOLine and EDGAR
were compared and crosschecked to obtain the final dataset of common conserved proteins.

Identification of intra-species conserved proteins
Primarily, for the identification of highly conserved proteins with available 3D models in all
Cd strains ( 95% sequence identity), the standalone release of NCBI BLASTp+ (v2.2.26) was
adapted from the NCBI ftp. Site (ftp://ftp.ncbi.nlm.nih.gov/blast/executables/blast+/LATEST/)
and installed on a local machine. Furthermore, a search was performed using NCTC13129 as a
random reference genome for all strains. Comparative genomics/proteomics approach was
Table 1. Strains of C. diphtheriae employed in the pan-modelome study with information on genomes statistics, disease prevalence and location
of isolation.
Strain

GPID

NCBI Accession

Genome Size (Mb)

Proteins

GC%

Location

Biovar

53.60

31A

PRJNA42399

NC_016799.1

2.53535

2258

Brazil

—

241

PRJNA42407

NC_016782.1

2.42655

2245

53.40

Brazil

—

BH8

PRJNA42423

NC_016800.1

2.48552

2223

53.60

Brazil

—

C7

PRJNA42401

NC_016801.1

2.49919

2230

53.50

USA

—

CDCE8392

PRJNA42405

NC_016785.1

2.43333

2135

53.60

USA

Mitis

HC01

PRJNA42409

NC_016786.1

2.42715

2162

53.40

Brazil

Mitis

HC02

PRJNA42411

NC_016802.1

2.46861

2179

53.70

Brazil

Mitis

HC03

PRJNA42415

NC_016787.1

2.47836

2186

53.50

Brazil

Mitis

HC04

PRJNA42417

NC_016788.1

2.48433

2190

53.50

Brazil

Gravis
Belfanti

INCA402

PRJNA42419

NC_016783.1

2.44907

2163

53.70

Brazil

PW8

PRJNA42403

NC_016789.1

2.53068

2200

53.70

USA

—

VA01

PRJNA42421

NC_016790.1

2.39544

2100

53.40

Brazil

Gravis

NCTC13129

PRJNA87

NC_002935.2

2.48863

2185

53.50

UK

Gravis

https://doi.org/10.1371/journal.pone.0186401.t001
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next adopted for selecting the highly conserved proteins using an all-against-all BLASTp analysis with a cut-off value of E = 0.0001, as in many other essentiality studies before [6, 13, 15, 18,
24].

Essential and non-host homologous (ENH) protein targets
A subtractive genomics approach was next followed for the selection of conserved targets,
which were essential to the bacteria [15]. Concisely, the set of proteins derived from the coremodelome of C. diphtheriae was subjected to the Database of Essential Genes (DEG) for
homology analyses. The DEG encompasses experimentally validated data of currently available
essential genomic elements like protein-coding genes and non-coding RNAs, from bacteria,
archaea and eukaryotes. For a bacterium, essential genes form a minimal genome, i.e., a set of
functional modules that has key roles in the emerging field of synthetic biology [25]. The cutoff
values used for BLASTp were: E-value = 0.0001, bit score 100 and identity  25% [15, 18].
The pool of essential genes was then subjected to NCBI-BLASTp (E-value = 0.0001, bit score
100 and identity  25%) against the human genome for filtering pathogen-essential hosthomologs [6]. The remaining set of pathogen-essential non-host homologs were additionally
crosschecked with NCBI-BLASTp PDB database using the default values to find any remote
structural similarity with the existing host homolog protein structures, keeping the cutoff level
to  15% for query coverage. The biochemical pathways of these proteins have been checked
using KEGG (Kyoto Encyclopedia of Genes and Genomes) [26], functionality using UniProt
(Universal Protein Resource) [27], virulence using PAIDB (Pathogenicity island database)
[28], and cellular localization using CELLO (subCELlular LOcalization predictor) [29]. The
final list of targets was based on criteria described by Barh et al., 2011 & Hassan et al., 2014 [15,
18].

Essential and host homologous (EH) protein targets
We further extended our analyses to the set of protein targets that were essential to C. diphtheriae but homologous to host proteins. The essential protein targets deviating from the cutoff

Fig 1. Overview of different computational steps employed for the identification of putative essential
targets (non-host homologous and host homologous) from the core-proteome of 13 C. diphtheriae
strains.
https://doi.org/10.1371/journal.pone.0186401.g001
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Fig 2. Intra-species subtractive modelomics workflow for conserved target identification in C.
diphtheriae species. The table represents the total number of protein sequences as an input data fed to the
MHOLline workflow (upper red arrow). The blue arrow represents the core genes of thirteen Cd strains. The
rectangular boxes show how this workflow processes and filters a large quantity of genomic data for putative
drug and vaccine target identification of a pathogen.
https://doi.org/10.1371/journal.pone.0186401.g002

values for essential non-host homologous proteins were treated as host homologous proteins.
This set of targets was also checked for pathway involvement, functional annotation virulence,
and cellular localization as mentioned above.

Computational identification of druggable pockets
The information obtained from 3D structures and druggability analyses are important features
for prioritizing and authenticating putative pathogen targets [30, 31]. As mentioned above, for
druggability analyses, the final list of essential non-host and host homologous protein targets
were subjected to DoGSiteScorer in PDB format [32]. The DoGSiteScorer is an automated
pocket detection and analysis tool for calculating the druggability of protein cavities. For each
detected cavity the tool returns the pocket residues and a druggability score ranging from 0 to
1. Values closer to 1 indicate highly druggable protein cavity, i.e. the predicted cavities are
likely to bind ligands with high affinity [32]. The DoGSiteScorer also calculates volume, depth,
surface area, lipophilic surface, and further parameters for each predicted cavity.

Ligand libraries preparation, virtual screening and docking analyses
The ligand libraries were prepared from four different sources, compounds from ZINC database (ZINC drug-like molecules, ZINC Natural Product), natural compounds from literature
survey [33] and the Di-terpenoid Iso-steviol derivatives (S1 Table). ZINC (drug-like molecules) contains 11,193 drug-like molecules, with Tanimoto cutoff level of 60% [34] and ZINC
(Natural Product) contain 11,203 molecules. Whereas, the small library of natural compounds
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contained 28 molecules and the library of Di-terpenoid Iso-steviol derivatives contained 31
molecules respectively. The structures of these molecules were constructed using MOE-Builder
tool. The 3D structures were modeled and partial charges were calculated using MOE (Molecular Operating Environment). The energies of the modeled molecules were minimized using
the energy minimization algorithm of MOE tool (gradient: 0.05, Force Field: MMFF94X, Chiral Constraint) [35]. The modeled molecules were saved in the.mol2 file format and subjected
to docking analysis.
The 3D structures of proteins were examined for structural errors such as missing atoms,
wrong bonds and protonation states in the MVD (Molegro Virtual Docker) [36]. The consensus set of protein cavities and those predicted with DogSiteScorer (druggability  0.80) were
compared with the MVD detected cavities, for all Cd targets. The maximum numbers of residues from DoGSiteScorer falling in the cavities detected by MVD were merged and final grid
was generated based on the consensus between the highest scoring pocket from DoGSiteScorer
and cavities detected by MVD for docking. The most druggable cavity was subjected to virtual
screening using MVD. The program comprises of three search algorithms for molecular docking analyses namely MolDock Simplex Evolution (SE), MolDock Optimizer [36] and Iterated
Simplex (IS). We employed the MolDock Optimizer search algorithm, which is based on a differential evolutionary algorithm, using the default parameters that are a) population size = 50,
b) scaling factor = 0.5 and c) crossover rate = 0.9. The orientations of docked molecules from
the library of natural compounds and from the derivatives of Di-terpenoid Iso-steviol were
analyzed in Chimera [37]. The 200 top ranked compounds (ZINC drug-like molecules, ZINC
Natural Product) for each target protein were evaluated for shape complementarity and hydrogen bond interactions. This led to the selection of a final set of compounds with polypharmacology and polypharmacy characteristics for target proteins in C. diphtheriae.

Results and discussion
Modelome prediction and conserved targets identification in C.
diphtheriae
Among 13 strains of C. diphtheriae species, our employed methodology produced high-confidence 3D structural models from orthologous proteins in C. diphtheriae species through the
efficient MHOLline workflow (Fig 3). A comparative structural genomics approach was

Fig 3. Efficiency of the MHOLline biological workflow for genome-scale modelome (3D models)
prediction. Predicted proteomes from the genomes of 13 C. diphtheriae strains were fed to the MHOLline
workflow in FASTA format. The grey bars represent the number of input data. The remaining bars (MHOLline
output data) show the number of not aligned sequences (G0, green bars), sequences for which there is a
template structure available at RCSB PDB (blue bars), and sequences with acceptable template structures
that were modeled in the MHOLline workflow (G2, red bars).
https://doi.org/10.1371/journal.pone.0186401.g003
PLOS ONE | https://doi.org/10.1371/journal.pone.0186401 October 19, 2017
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followed where all the G2 sequences classified as “Very High”, “High”, “Good” and “Medium
to Good quality” by MHOLline, from the 12 Cd strains, were aligned to the Cd NCTC13129
strain as a reference genome. First, we identified a set of common conserved proteins with a
pre-defined sequence similarity of 95–100%. This resulted in a set of 463 protein sequences,
being conserved in all Cd strains (S3 Table).

Protein targets as putative drug and vaccine candidates
The identification of essential proteins in C. diphtheriae was carried out where the core-modelome was compared to DEG (Database of Essential Genes). This filter drastically reduced the
number of selected targets to 23 final targets. Further comparison of the corresponding protein
sequences to the human host proteome resulted in a set of 8 targets as essential non-host
homologous (ENH, Table 2) and a set of 15 targets as essential host homologous proteins (EH,
Table 3).

Prioritization parameters for drug targets and vaccine candidates
There are several factors that can aid in determining potential therapeutic targets [30]. For vaccine candidates, the information about subcellular localization is important: Proteins that contain transmembrane motifs are favored [24, 30, 38, 39]. The 23 essential proteins have a low
molecular weight and all are localized in the cytoplasmic compartment of C. diphtheriae
(Tables 2 & 3). After the druggability evaluation using DoGSiteScorer [32] for both essential
non-host and host homologous conserved targets from C. diphtheriae, we could predict at least
one druggable cavity for each Cd target. The host homologous proteins as therapeutic targets
could adversely affect the host. Therefore, the first step in numerous in silico drug target identification approaches are filtering proteins homologous to host proteome. Thus, we only consider the eight pathogen-essential non host homologs for the docking studies [13, 15, 40]. For
the eight pathogen-essential non host homologs (S2 Table) glpX, nusB, rpsH, hisE, DIP1084,
DIP0983, smpB, and bioB 3, 0, 1, 0, 2, 0, 1 and 3 cavities with score > 0.80 were predicted. The
cavity of each protein exhibiting the highest druggability score was subjected to docking analyses. The numbers of predicted cavities with their respective druggability scores are given in
Tables 2 & 3.
The identified eight non-host homologous and essential Cd proteins could be novel therapeutic targets for Corynebacterium diphtheriae.
As per our knowledge, glpX, hisE and bioB proteins have been reported as potential drug
target in Mtb. Protein nusB is a member of Nus-transcription Factor family that help bacteria
in the process of elongation, transcription: translation coupling and termination. Some members of this family (nusG) has already been reported as drug target. Furthermore, rpsH and
smpB are also reported as potential drug target by Folador et al., 2016 in their in silico study
[41]. Protein DIP1084 is Putative iron transport membrane protein (FecCD-family) and
DIP0983 is uncharacterized Hypothetical Protein that need to be characterized experimentally.
Hence, these protein could be a good therapeutic target against Cd.

Virtual screening and molecular docking
For each target protein (glpX, nusB, rpsH, hisE, DIP1084, DIP0983, smpB, and bioB) four different libraries were separately screened. A total of 28 molecules from natural compounds
library and 31 compounds from the derivatives of Di-terpenoid Iso-steviol library were
docked. Furthermore, top 200 drug-like molecules from virtual screening analyses of two large
libraries (ZINC drug-like molecules, ZINC Natural Product) were examined one-by-one for
the selection of the final set of promising molecules that showed favorable interactions with

PLOS ONE | https://doi.org/10.1371/journal.pone.0186401 October 19, 2017
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Table 2. Drug and/or vaccine target prioritization parameters and functional annotation of the eight essential non-host homologous putative
targets.
Gene and
protein codes

Official full name

Cavities
with DSa
> 0.80

Cavities
with DSa,g >
0.60
and < 0.80

Mol.
Wtb
(KDa)

Functionsc

Pathwayse

Virulencef

NP_939692.1,
nusB

Transcription
antitermination protein
NusB/ N utilization
substance protein B
homolog

0

2

20.382

MF: RNA binding.
BP: DNA-templated
transcription,
termination, regulation
of transcription, DNAtemplated.

unknown

No

NP_939612.1,
hisE

Phosphoribosyl-ATP
pyrophosphatase

0

1

9.877

MF: RNA binding,
phosphoribosyl-ATP
diphosphatase activity
BP: histidine
biosynthetic process

Cytoplasm

Biosynthesis of
amino acids

Yes

NP_939445.1,
DIP1084

Iron ABC transporter
membrane protein/
Putative iron transport
membrane protein,
FecCD-family

2

3

35.470

MF: Transporter
activity
BP: Transport

Membrane

The ATP-binding
cassette (ABC)
transporters form
one of the largest
known protein
families

Yes

NP_939345.1,
DIP0983

Hypothetical protein
DIP0983/
Uncharacterized protein

0

4

28.193

MF: possible lysine
decarboxylases
(Pfam)/52% sequence
identity with PDB
Template 1WEK.
BP: A pyridoxalphosphate protein. Also
acts on 5-hydroxy-Llysine (IUBMB
Comments)

Cytoplasm

unknown

Yes

NP_939302.1,
glpX

Fructose
1,6-bisphosphatase II

3

2

35.589

MF: fructose
1,6-bisphosphate
1-phosphatase activity,
metal ion binding.
BP: gluconeogenesis,
glycerol metabolic
process

Carbohydrate
Metabolism

No

NP_939123.1,
smpB

SsrA-binding protein

1

2

18.784

MF: RNA binding

Cytoplasm

unknown

Yes

NP_938900.1,
rpsH

30S ribosomal protein S8

1

1

14.292

MF: rRNA binding,
structural constituent of
ribosome
BP: Translation

Extracellula/
Cytoplasm

unknown

No

NP_938502.1,
bioB

Biotin synthase

3

1

38.224

MF: 2 iron, 2 sulfur
cluster binding, 4 iron 4
sulfur cluster binding,
biotin synthase activity,
iron ion binding
BP: biotin biosynthetic
process

Cytoplasm

Biotin metabolism

Yes

Cellular
componentd

Cytoplasm

a

Druggability predicted with DoGSiteScorer software. A druggability score above 0.60 is considered to be good, but a score above 0.80 is favored [32].
Molecular weight was determined using ProtParam tool (http://web.expasy.org/protparam/).

b
c

Molecular function (MF) and biological process (BP) for each target protein was determined using UniProt.

d

Cellular localization of pathogen targets was performed using CELLO.
KEGG was used to find the role of these targets in different cellular pathways.

e
f

PAIDB was used to check if the putative targets are involved in the pathogen’s virulence.

g

DS = Drug Score

https://doi.org/10.1371/journal.pone.0186401.t002

PLOS ONE | https://doi.org/10.1371/journal.pone.0186401 October 19, 2017

8 / 25

Therapeutic targets identification for Corynebacterium diphtheriae

Table 3. Drug and/or vaccine target prioritization parameters and functional annotation of the fifteen essential host homologous putative targets.
Gene and
protein
codes

Official full name

Cavities
with DSa
> 0.80

Cavities
with DSa,g
> 0.60
and < 0.80

Mol.
Wtb.
(KDa)

Functionsc

Cellulard
component

Pathwayse

Virulencef

NP_938651.1
RecR

Recombination protein
RecR

0

2

23.901

MF: DNA binding, metal ion
binding
BP: DNA recombination,
DNA repair

Cytoplasm

Homologous
recombination

Yes

NP_938792.1
Putative electron
DIP0411
transport related protein

0

2

19.950 MF: Antioxidant activity,
oxidoreductase activity

Cytoplasm/
Membrane

—

Yes

NP_938922.1
rpsM

30S ribosomal protein
S13

0

1

13.777

MF: rRNA binding, structural
constituent of ribosome, RNA
binding
BP: Translation

Cytoplasm

Ribosome

No

NP_939046.1
DIP0672

Putative uptake
hydrogenase small
subunit

2

0

43.949

MF: 3 iron, 4 sulfur cluster
binding, 4 iron, 4 sulfur
cluster binding, ferredoxin
hydrogenase activity, metal
ion binding

Cytoplasm

Microbial
metabolism in
diverse
environments

Yes

NP_939341.1
dapD,
DIP0979

Tetrahydropicolinate
succinylase
EC 2.3.1.117

1

1

33.780

MF:
2,3,4,5-tetrahydropyridine2,6-dicarboxylate Nsuccinyltransferase activity,
magnesium ion binding
BP: diaminopimelate
biosynthetic process, lysine
biosynthetic process via
diaminopimelate

Cytoplasm

Biosynthesis of
amino acids

Yes

NP_939343.1
DIP0981

Putative
succinyltransferase
EC 2.3.1.117

1

1

33.039

MF:
2,3,4,5-tetrahydropyridine2,6-dicarboxylate Nsuccinyltransferase activity

Cytoplasm

Biosynthesis of
amino acids

Yes

NP_939460.1
ilvH, DIP1099

Acetolactate synthase
small subunit
EC 2.2.1.6

1

3

19.063

MF: acetolactate synthase
activity, amino acid binding
BP: branched-chain amino
acid biosynthetic process

Cytoplasm/
Membrane

2-Oxocarboxylic
acid metabolism

Yes

NP_939590.1
cobM

Precorrin-4
C11-methyltransferase
EC 2.1.1.133

1

2

27.181

MF: precorrin-2
dehydrogenase activity,
precorrin-4
C11-methyltransferase
activity
BP: cobalamin biosynthetic
process, porphyrin-containing
compound biosynthetic
process

Cytoplasm

Porphyrin and
chlorophyll
metabolism

Yes

NP_939786.1
DIP1438

Putative transport
membrane protein

4

3

44.215

MF: Transporter activity
BP: transmembrane
transport

Membrane

The ATP-binding
cassette (ABC)
transporters

Yes

NP_939832.1
DIP1484

Putative
uroporphyrinogen III
methyltransferase

3

2

28.296

MF: Methyltransferase
activity
BP: oxidation-reduction
process

Cytoplasm

Porphyrin and
chlorophyll
metabolism

Yes

NP_939958.1
aroH,
DIP1616

Phospho-2-dehydro3-deoxyheptonate
aldolase
EC 2.5.1.54

2

3

50.805

MF: 3-deoxy7-phosphoheptulonate
synthase activity
BP: aromatic amino acid
family biosynthetic process

Cytoplasm

Biosynthesis of
amino acids

Yes

(Continued)
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Table 3. (Continued)
Gene and
protein
codes

Official full name

Cavities
with DSa
> 0.80

Cavities
with DSa,g
> 0.60
and < 0.80

Mol.
Wtb.
(KDa)

Functionsc

Cellulard
component

Pathwayse

Virulencef

NP_940018.1
DIP1680

Putative GTP
cyclohydrolase 1 type 2
EC 3.5.4.16

2

1

40.657

MF: GTP binding, GTP
cyclohydrolase I activity,
metal ion binding
BP: 7,8-dihydroneopterin 3’triphosphate biosynthetic
process

Cytoplasm

—

Yes

NP_940228.1
cysE,
DIP1891

Serine
acetyltransferase EC
2.3.1.30

1

0

20.208

MF: serine Oacetyltransferase activity
BP: cysteine biosynthetic
process from serine

Cytoplasm

Carbon
metabolism

Yes

NP_940284.1
DIP1952

Putative pyruvate
dehydrogenase

3

1

62.497

MF: Catalytic activity,
magnesium ion binding,
thiamine pyrophosphate
binding

Cytoplasm

(PYRUVATE
METABOLISM)
Nicotinate and
nicotinamide
metabolism

Yes

NP_940605.1
DIP2303

Putative DNA
protection during
starvation protein

0

1

18.223

MF: Ferric iron binding,
oxidoreductase activity,
oxidizing metal ions
BP: cellular iron ion
homeostasis, response to
stress

Cytoplasm

—

Yes

a

Druggability predicted with DoGSiteScorer software. A druggability score above 0.60 is usually considered, but a score above 0.80 is favored [32].
Molecular weight was determined using ProtParam tool (http://web.expasy.org/protparam/).

b
c

Molecular function (MF) and biological process (BP) for each target protein was determined using UniProt.

d

Cellular localization of pathogen targets was performed using CELLO.
e
KEGG was used to find the role of these targets in different cellular pathways.
f

PAIDB was used to check if the putative targets are involved in the pathogen’s virulence.

g

DS = Drug Score.

https://doi.org/10.1371/journal.pone.0186401.t003

the ENH targets. The biological importance and an analysis of the predicted protein-ligand
interaction/s for each target are described here. The molecule names, ZINC codes and MolDock scores for the selected ligands, as well as the number of predicted hydrogen bonds with
the protein cavity residues involved in these interactions, are shown below (Tables 4–11) for
each target protein. The predicted binding modes of selected ligands are also shown for each
pathogen target in Figs 5–12.

Validation of docking protocol
To validate the accuracy of MolDock program (MVD), the co-crystallized ligand of Biotin
synthase, bioB (PDB ID; 1R30) was extracted and then re-docked into the binding pocket of
receptor protein. The RMSD between docked and co-crystallized ligand was found to be 1.81
A˚, which shows that the adopted docking protocol is valid and can be used to correctly predict
the binding pose of the ligands [35, 42]. The superposition of co-crystallized ligands and
docked is shown in Fig 4.
NP_939302.1 (glpX, Fructose 1, 6-bisphosphatase II) is a key enzyme of gluconeogenesis
and catalyzes the hydrolysis of fructose 1, 6-bisphosphate to form fructose 6-phosphate and
orthophosphate. A reverse reaction catalyzed by phosphofructokinase in glycolysis, and the
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Table 4. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected best-ranked molecules against
NP_939302.1 (glpX, Fructose 1,6-bisphosphatase II).
Compounds

MolDock Score

H-Bond/Residues

Rhein

-64.1265

3/ Val95, Asp197

Jacarandic Acid

-62.0658

4/ Asp96, Thr98, Asp197, Pro221

16-hydrazonisosteviol

-64.2107

5/ Asp93, Val95, Asp96, Val198

16-oxime,
17-hydroxyisosteviol

-69.6824

4/ Asp93, Asp96, Thr98

Benzyl ester isosteviol lactone

-69.8464

3/ Asp93, Asp197, Glu222

ZINC00042420

-106.97

3/ Arg175, Arg197, Val198

ZINC13142972

-109.648

3/ Asp93, Asp197, Glu222

ZINC67912153

-135.111

13/Gly64, Glu65, Asp93, Val95, Gly97, Thr98, Phe127, Arg175,
Glu222

ZINC67902753

-121.762

8/Glu65, Val95, Thr98, Glu222

ZINC38143633

-123.150

11/Lys37, Asp93, Val95, Asp96, Gly97, Thr98

Plant derived natural
compounds
Derivative of diterpenoid
isosteviol

ZINC Compounds
ZINC *NP Compounds

*NP = Natural Product (http://zinc.docking.org/catalogs/acdiscnp)
https://doi.org/10.1371/journal.pone.0186401.t004

product, fructose 6-phosphate, is an important precursor in various biosynthetic pathways [43].
In all organisms, gluconeogenesis is an important metabolic pathway that allows the cells to synthesize glucose from non-carbohydrate precursors, such as organic acids, amino acids and glycerol. FBPases are members of the large superfamily of lithium sensitive phosphatases, which
includes three families of inositol phosphatases and FBPases (the phosphoesterase clan CL0171,
3167 sequences, Pfam data base). The FBPases are already reported as targets for the development of drugs for the treatment of noninsulin dependent diabetes [44, 45]. Based on a comparison with a crystallographic structure of the glpX template (PDB ID: 1NI9, GlpX from Escherichia
coli), none of the active site residues were identified. The docking analysis was performed utilizing the highest scoring pocket obtained from DoGSiteScorer. Table 4 shows a set of 10 promising ligands according to their minimum energy values and the maximum number of hydrogen
bond interactions from the four aforementioned libraries. Compounds ZINC67912153,
ZINC13142972, Jacarandic Acid and 16-hydrazonisosteviol are shown in Fig 5.
NP_939692.1 (nusB, Transcription antitermination protein NusB) is a prokaryotic transcription factor involved in antitermination processes, during which it interacts with the
mRNA nut site at boxA portion. The crystal structure of M. tuberculosis and E. coli NusB proteins suggest that the basic N-terminal region of the molecule associates with the rRNA BoxA.
Hypothetically, this is indicative of the so-called arginine rich RNA binding motif (ARM) in

Table 5. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939692.1 (nusB,
Transcription antitermination protein NusB).
Compounds
Plant derived natural compounds

MolDock Score

H-Bond/Residues

Rhein

-78.0652

1/ Asp36

Jacarandic Acid

-68.1913

3/ Asp36, Glu91, Arg98

Derivative of diterpenoid isosteviol

16-hydrazonisosteviol

-92.7911

2/ Glu31, Leu73

ZINC Compounds

ZINC00053531

-99.4716

3/ Asp34, Asp36, Ala69

ZINC19899354

-114.966

3/ Asp36, Ala69, Asp77

ZINC67911826

-131.288

7/Ala30, Glu31, Asp34, Ile35, Arg102

ZINC NP Compounds

ZINC15043210

-124.580

7/ Glu31, Ile35, Leu73 Glu91, Arg102

ZINC31168395

-131.442

6/ Glu31, Asp34, Ala69, Leu73, Asp77, Arg102

https://doi.org/10.1371/journal.pone.0186401.t005
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Table 6. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938900.1 (rpsH, 30S
ribosomal protein S8).
Compounds

MolDock Score

Plant derived natural compounds
Derivative of diterpenoid isosteviol

H-Bond/Residues

Rhein

-48.8803

3/ Asp5, Arg15

Jacarandic Acid

-49.3506

4/ Ser12, Val77

16-hydrazonisosteviol

-68.2446

3/ Asp5, Arg13, Arg79

17-hydroxyisosteviol

-64.5855

5/ Asp5, Arg79

16–17 dihydroxyisosteviol

-56.3868

4/ Asp5, Arg79

16-oxime, 17-hydroxyisosteviol

-65.1995

4/ Ser26, Ser29, Ser30

ZINC15221730

-103.636

5/ Ala8, Arg15, Arg79

ZINC71913776

-87.1474

5/ Arg15, Arg79

ZINC72333100

-104.807

3/ Arg15, Arg79, Val80

ZINC35457686

-107.091

10/Ala8, Ser12, Arg15, Val77, Arg78, Arg79, Lys82

ZINC67903079

-131.210

10/ Asp5, Ser12, Arg15, Arg78, Arg79, Lys82

ZINC31163223

-100.684

7/ Ala8, Asp9, Arg78, Arg79, Lys82

ZINC Compounds

ZINC NP Compounds

https://doi.org/10.1371/journal.pone.0186401.t006

Table 7. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938502.1 (bioB, Biotin synthase).
Compounds
Plant derived natural
compounds

MolDock
Score

H-Bond/Residues
3/ Tyr183, Asn184, His185

Rhein

-72.2918

Jacarandic Acid

-98.0169

2/ Ala132, Glu188

16-hydrazonisosteviol

-107.55

4/ Gly165, Tyr183, Asn184, Glu188

17-hydroxyisosteviol

-92.2141

4/ Cys93, Ala132, Val134, Tyr183

16-oxime,
17-hydroxyisosteviol

-98.9592

5/ Glu95, Val134, Glu188, Arg206, Thr323

Benzyl ester isosteviol
lactone

-89.8881

5/ Ala132, Val134, Gly165, Asn184

ZINC Compounds

ZINC16952914

-119.354

5/ Val134, Ile164, Gly165, Asn184, Asn186

ZINC NP Compounds

ZINC77269615

-164.853

17/Cys86, Phe92, Cys93, Ser94, Gln95, Ala132, Val134, Ser163,
Asn184, Asn186, Arg206

ZINC04098512

-162.050

14/ Cys86, Cys90, Cys93, Ala132, Val134, Asn184, Asn186, His201,
Arg206, Asp256, Thr323

ZINC15112225

-142.080

10/ Phe92, Cys93, Ser94, Gln95, Asn186, Arg206, Asn253

Derivative of diterpenoid
isosteviol

https://doi.org/10.1371/journal.pone.0186401.t007

Table 8. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939612.1 (hisE,
Phosphoribosyl-ATP pyrophosphatase).
Compounds
Plant derived natural compounds

MolDock Score

H-Bond/Residues

Rhein

-54.9556

1/ Tyr84

Jacarandic Acid

-61.0241

3/ Leu87

Derivative of diterpenoid isosteviol

16–17 dihydroxyisosteviol

-70.8496

3/ Leu65, Tyr84

ZINC Compounds

ZINC05809437

-89.6781

1/ Asp5

ZINC NP Compounds

ZINC38143703

-99.499

4/ Thr79, Ile83, Leu87

ZINC67913372

-97.997

5/ Gly36, Ile62, Ile83, Tyr84

https://doi.org/10.1371/journal.pone.0186401.t008
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Table 9. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939123.1 (smpB,
SsrA-binding protein).
Compounds
Plant derived natural compounds
Derivative of diterpenoid isosteviol

MolDock Score

H-Bond/Residues
3/ Ser16, Ser114, Leu115

Rhein

-67.698

Jacarandic Acid

-52.3689

1/ Asn69

16-hydroxyisosteviol

-53.2141

4/ Ser50, Thr52, Asn69

16-hydrazonisosteviol

-64.6203

3/ Thr52, Asn67

16–17 dihydroxyisosteviol

-59.7364

3/ Ser16, Lys19, Val49

ZINC01414475

-86.7944

3/ Thr52, Asn67, Asn69

ZINC17128469

-74.5349

3/ Ser16, Leu51, Thr52

ZINC31168211

-158.056

12/ Asn9, Ser16, Val49, Ser50, Thr52, Asp53, Ser54, Thr109

ZINC33832449

-134.974

10/ Asn9, Ser16, Asn17, Val49, Ser50, Thr52, Asp53

ZINC04096316

-137.613

9/ Asn9, Ser10, Ser16, Asn17, Lys19, Val49, Ser50, Thr52

ZINC Compounds
ZINC NP Compounds

Table 10. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939445.1 (DIP1084,
Putative iron transport membrane protein, FecCD-family).
Compounds

MolDock Score

H-Bond/Residues

Rhein

-66.4406

1/ Ser164

Jacarandic Acid

-77.5981

1/ Gly265

16-hydrazonisosteviol

-96.3945

4/ Tyr97, Ser164, Ile266

17-hydroxyisosteviol

-90.1488

4/ Tyr97, Ser164, Ile266

Benzyl ester isosteviol lactone

-71.4733

4/ Tyr97, Ser164

ZINC01645563

-95.7116

5/ Tyr97, Ser102, Ser164, Ile266
5/ Ser103, Ser106, Thr110, Ser164, Ser168

Plant derived natural compounds
Derivative of diterpenoid isosteviol

ZINC Compounds

ZINC NP Compounds

ZINC13142972

-111.185

ZINC62023045

-103.542

4/ Tyr97, Ser102, Ser106, Ser164

ZINC70454922

-155.667

10/ Tyr97, Ser102, Ser106, Ser168, Ser172, Met191, Gly319

ZINC31167925

-135.535

10/ Tyr97, Ser164, Ser168, Met191, Gly265, Ile266, Thr322

ZINC04963990

-127.671

8/ Asp95, Tyr97, Ser106, Met191, Ile266, Phe268

https://doi.org/10.1371/journal.pone.0186401.t010

Table 11. Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939345.1 (DIP0983,
hypothetical protein DIP0983).
MolDock Score

H-Bond/Residues

Plant derived natural compounds

Compounds
Rhein

-55.7819

3/ Cys13, Leu17, Asp177

Jacarandic Acid

-80.8294

3/ Cys13, Gly14

Derivative of diterpenoid
isosteviol

17-hydroxyisosteviol

-95.9025

2/ His11, Cys13

16–17
dihydroxyisosteviol

-83.7226

2/ His11, Cys13

ZINC Compounds

ZINC00114311

-125.423

6/ Arg10, Arg155, Gly172

ZINC00211173

-98.6064

7/ Arg10, Gly106, Arg155, Gly174, Asp177

ZINC NP Compounds

ZINC01427915

-112.22

6/ Arg10, Ala77, Arg78, Gly172, Gly174

ZINC04836994

-136.847

5/ Arg10, Gly106, Ile131, Glu132

ZINC32004947

-146.72

5/ Arg10, Gly106, Ile131, Glu132

ZINC67911471

-176.091

13/ Asn8, Cys13, Ser76, Ala77, Arg78 Arg150, Arg155, Gly174,
Thr175

ZINC31163223

-162.908

12/ Asn8, Arg10, His11, Arg150, Arg155, Gly172, Thr175

ZINC04096393

-148.423

10/ Glu9, Arg10, Ala77, Arg78, Arg155, Lys156, Thr175

https://doi.org/10.1371/journal.pone.0186401.t011
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Fig 4. Superposition of co-crystallized and Docked ligand; Dark Khaki represents the co crystallized
ligand and Dark Cyan the re-docked conformation of the ligand.
https://doi.org/10.1371/journal.pone.0186401.g004

the bacteriophage N protein, HIV tat and HIV rev. This suggestion is supported by the presence of a phosphate-binding site at the N-terminal end of α-A in each NusB protomer that
includes a pair of conserved arginines, Arg10 and Arg14 [46]. The bismuth-dithiol solutions
have been shown to selectively inhibit Escherichia coli rho transcription termination factor
[47]. A comparison between the crystallographic structures of the NusB template (PDB ID:
1EYV, NusB from M. tuberculosis) and our modeled structure reveals that the conserved arginines were located at position 12 and 16 (Arg12 and Arg16) and are likely to contribute in the
interactions. Although none of these residues are predicted to form hydrogen bonds with
selected docked ligands, these molecules were predicted to interact with other residues in the
pocket. Table 5 shows the 8 selected ligands from all the four libraries according to their

Fig 5. A-I: 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939302.1 (glpX, Fructose 1,6-bisphosphatase II) with Jacarandic Acid (CID 73645). A-II: 3D surface
representation of the docking analyses for the structures of Jacarandic Acid with glpX protein. Figs B-I, II, C-I,
II & D-I, II represent same information for compounds 16-hydrazonisosteviol, ZINC13142972 and
ZINC67912153 respectively, for the same protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g005

PLOS ONE | https://doi.org/10.1371/journal.pone.0186401 October 19, 2017

14 / 25

Therapeutic targets identification for Corynebacterium diphtheriae

Fig 6. A-I: 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939692.1 (nusB, Transcription antitermination protein NusB) with Jacarandic Acid (CID 73645). A-II: 3D
surface representation of the docking analyses for the structures of Jacarandic Acid with nusB protein. Figs
B-I, II, C-I, II and D-I, II represent same information for compounds 16-hydrazonisosteviol, ZINC00053531
and ZINC15043210 respectively, for the same protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g006

minimum energy values and the number of hydrogen bond interactions. The compounds
ZINC15043210, ZINC00053531 Jacarandic Acid and 16-hydrazonisosteviol are shown in
(Fig 6). A decent binding mode and good shape complementarity was observed in these
complexes.
NP_938900.1 (rpsH, 30S ribosomal protein S8) is an important RNA-binding protein that
inhabits a central position within the small ribosomal subunit. It widely interacts with 16S
rRNA and is vital for the correct folding of the central domain of the rRNA. The protein rpsH
S8 also controls the synthesis of numerous ribosomal proteins by binding to mRNA. It binds
exactly to very similar sites in the two RNA molecules. It is a ribosomal protein that has
medium-size, and its role as a significant primary RNA-binding protein in the 30S subunit is
discovered recently. The S8 mutations within the protein have been shown to result in defective ribosome assembly. In Escherichia coli, the S8-binding site within 16S rRNA has been
investigated independently by a number of techniques including nuclease protection, RNA–
protein crosslinking, RNA modification, hydroxyl-radical footprinting and chemical probing.
The rpsH S8 protein is also one of the principal regulatory elements that control ribosomal
protein synthesis by the translational feedback inhibition mechanism discovered by Nomura
and colleagues [48]. It regulates the expression of the spc operon that encodes, in order, the
ten ribosomal proteins L14, L24, L5, S14, S8, L6, L18, S5, L30 and L15 [49]. The active site residues of rpsH, based on a comparison with its template structure were Arg86, Tyr88, Ser107,
Ser109, Gly124, Gly125 and Glu126. However, none of the molecules interacts with these residues (Table 6); nonetheless they are predicted to interact with other residues of the binding
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Fig 7. A-I 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_938900.1 (rpsH, 30S ribosomal protein S8) with Jacarandic Acid (CID 73645). A-II: 3D surface
representation of the docking analyses for the structures of Jacarandic Acid with rpsH protein. Figs B-I, II, C-I,
II and D-I, II represent same information for compounds 17-hydroxyisosteviol ZINC15221730 and
ZINC35457686 respectively, for the same cavity.
https://doi.org/10.1371/journal.pone.0186401.g007

cavity predicted by DoGSiteScorer. The predicted binding mode of best scoring compounds
each library ZINC35457686, ZINC15221730, Jacarandic Acid and 17-hydroxyisosteviol are
shown in Fig 7.
NP_938502.1 (bioB, Biotin synthase) catalyzes the final step in the biotin biosynthetic
pathway by converting dethiobiotin (DTB) to biotin. This reaction uses organic radical chemistry for inserting sulfur atom between non activated carbons C6 and C9 of DTB. BioB is a
member of the “radical SAM” or “AdoMet radical” superfamily, which is categorized by the
presence of a conserved CxxxCxxC sequence motif (C, Cys; x, any amino acid) that synchronizes an essential Fe4S4 cluster, as well as by the use of S-adenosyl-Lmethionine (SAM or AdoMet) for radical generation. AdoMet radical enzymes act on a wide variety of biomolecules.
For example, BioB and lipoyl-acyl carrier protein synthase (LipA) are involved in vitamin biosynthesis; lysine 2,3-aminomutase (LAM) facilitates the fermentation of lysine; class III ribonucleotide reductase (RNR) and pyruvate formate lyase (PFL) catalyze the formation of glycyl
radicals in their respective target proteins; and spore photoproduct lyase repairs ultraviolet
light-induced DNA damage [50]. The protein bioB was reported as putative drug target in C.
diphtheriae by Barh et al., 2011 in their in silico study [15]. A comparison between our modeled protein and template structures suggest Cys86, Cys90, Cys93 and Arg291 as the active residues. Although, only Cys86, Cys90 and Cys93 were found to interact with the compounds
from our prepared libraries, the molecules were predicted to interact with other residues in the
pocket. The binding mode of compounds with active site residues and low scores suggest a set
of 10 molecules (Table 7) as promising leads from our four libraries. The predicted binding
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Fig 8. A-I 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_938502.1 (bioB, Biotin synthase) with Rhein (CID 10168). A-II: 3D surface representation of the docking
analyses for the structure of Rhein with bioB protein. Figs B-I, II, C-I, II & D-I, II represent same information for
compounds 16-oxime, 17-hydroxyisosteviol, ZINC16952914 and ZINC77269615 respectively, for the same
protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g008

modes of Jacarandic Acid, 16-oxime, 17-hydroxyisosteviol, ZINC16952914 and
ZINC77269615 are shown in Fig 8.
NP_939612.1 (hisE, Phosphoribosyl-ATP pyrophosphatase) is the second enzyme in the
histidine-biosynthetic pathway, hydrolyzing irreversibly phosphoribosyl-ATP to phosphoribosyl-AMP and pyrophosphate. It is encoded by the hisE gene, which is present as a separate gene in many bacteria and archaea but is fused to hisI in other bacteria, fungi and
plants. As it is essential for growth as seen in in vitro experiments, HisE is a potential drug
target for tuberculosis [51]. A comparison of template and target protein structures here
showed that there was no reported information about ligand-residue/s association in the
active site cavity. Hence, the cavity chosen for virtual screening was simply the one that presented the highest DogSiteScorer druggability score (>80). A list of best dock molecules is
shown below (Table 8). The binding patterns of Jacarandic Acid, 16–17 dihydroxyisosteviol, ZINC05809437 and ZINC67913372 are shown in Fig 9.
NP_939123.1 (smpB, SsrA-binding protein) is a small protein B (SmpB), which is very useful for biological functions of tmRNA. In bacteria, a hybrid RNA molecule that combines the
functions of both messenger and transfer RNAs rescues stalled ribosomes, and targets aberrant, partially synthesized proteins for proteolytic degradation. The flexible RNA molecule
adopts an open L-shaped conformation and SmpB binds to its elbow region, stabilizing the
single-stranded D-loop in an extended conformation. The most prominent feature of the
structure of tmRNAΔ is a 90o rotation of the TѰC-arm around the helical axis. Because of this
important conformation, the SmpB–tmRNA D-complex positioned into the A-site of the
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Fig 9. A-1 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939612.1 (hisE, Phosphoribosyl-ATP pyrophosphatase) with Jacarandic Acid (CID 73645). A-II: 3D
surface representation of the docking analyses for the structure of Jacarandic Acid with hisE protein. Figs B-I,
II, C-I, II & D-I, II represent same information for compounds 16–17 dihydroxyisosteviol, ZINC05809437 and
ZINC67913372 respectively, for the same protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g009

Fig 10. A-I 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939123.1 (smpB, SsrA-binding protein) with Rhein (CID 10168). A-II: 3D surface representation of the
docking analyses for the structure of Rhein with smpB protein. Figs B-I, II, C-I, II & D-I, II represent same
information for compounds 16-hydroxyisosteviol ZINC01414475 & ZINC31168211 respectively, for the same
protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g010
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Fig 11. A-I 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939445.1 (DIP1084, Putative iron transport membrane protein, FecCD-family) with Jacarandic Acid (CID
73645). A-II: 3D surface representation of the docking analyses for the structure of Jacarandic Acid with
DIP1084, Putative iron transport membrane protein. Figs B-I, II, C-I, II & D-1, II D represent same information
for compounds 16-hydrazonisosteviol ZINC13142972 and ZINC70454922 respectively, for the same protein
cavity.
https://doi.org/10.1371/journal.pone.0186401.g011

ribosome orients SmpB towards the small ribosomal subunit, and directs tmRNA towards the
elongation-factor binding region of the ribosome. The tmRNA–SmpB rescue system is ubiquitous in bacteria, and is also found in some chloroplasts and mitochondria [52]. In this case the
template structure (PDB ID: 1P6V) did not contain any ligand, and no reported information
was found about the ligand-residue interaction in their cavities. Therefore, amongst the cavities identified by MVD, the best cavity for docking analysis was chosen in consensus with highest druggability score from the DogSiteScorer. ZINC31168211 was found to form the network
of 12 hydrogen bonds with Asn9, Ser16, Val49, Ser50, Thr52, Asp53, Ser54, Thr109. Table 9
lists top compounds from respective libraries selected for this target while the binding modes
of Rhein, 16-hydroxyisosteviol, ZINC01414475 and ZINC31168211 are also shown (Fig 10).
NP_939445.1 (DIP1084, Putative iron transport membrane protein, FecCD-family) The
Pfam search for the protein showed that it has two main components, FecCD and ABC_trans.
The FecCD is a subfamily of bacterial binding-protein-dependent transport systems family
constituting transport system permease proteins involved in the transport of numerous compounds through the membrane. These transporters tend to catalyze the thermodynamically
unfavorable translocation of substrates against a transmembrane concentration gradient
through the coupling to a second, energetically favorable process. ABC systems can be categorized in three functional groups, as follows. Importers mediate the uptake of nutrients in prokaryotes. The nature of the substrates that are transported is very wide, including mono- and
oligosaccharides, organic and inorganic ions, amino acids, peptides, iron-siderophores, metals,
polyamine cations, opines, and vitamins [53]. Exporters are involved in the secretion of various molecules, such as peptides, lipids, hydrophobic drugs, polysaccharides, and proteins,
including toxins such as hemolysin. The third category of systems is apparently not involved
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Fig 12. A-1: 3D cartoon representation of the docking analyses for the most druggable protein cavity of
NP_939345.1 (DIP0983, Hypothetical protein DIP0983) with Jacarandic Acid (CID 73645). A-II: 3D surface
representation of the docking analyses for the structure of Jacarandic Acid with Hypothetical protein DIP0983.
Figs B-I, II, C-I, II & D-I, II represent same information for compounds 17-hydroxyisosteviol, ZINC00211173
and ZINC67911471 respectively, for the same protein cavity.
https://doi.org/10.1371/journal.pone.0186401.g012

in transport, with some members being involved in translation of mRNA and in DNA repair.
Table 10 shows a set of 11 high scoring compounds against the proposed target. Compound
ZINC70454922 from ZINC NP library was predicted to form ten hydrogen bonds with relatively low docking score (Fig 11).
NP_939345.1 (DIP0983, Hypothetical protein DIP0983) is a conserved hypothetical protein. It is annotated as a possible lysine decarboxylase (LDC) in the Pfam database (PF03641)
[54] due to the presence of the highly conserved PGGxGTxxE motif. Some enzymes i:e “Lonely
Guy” LOG are often mis-annotated as lysine decarboxylases enzymes; it is apparently responsible for catalyzing L-lysine decarboxylation to produce the polyamine metabolite cadaverine
[55]. Conversely, this annotation is not supported by any biochemical or functional data in
any of the PGGxGTxxE motif containing LDC identified so far. This motif is highly conserved
among a vast number of proteins with unknown function, predicted from bacterial, yeast, and
plant; in Arabidopsis thaliana, all the genome-annotated LOG proteins are identified as LDC
like proteins by protein family. Based on sequence BLAST against the PDB, LOG from Claviceps purpurea shares more than 30% identical residues with crystal structures of LDC-like proteins of unknown function, whose structures are already determined. Recently, lysine
decarboxylase has been reported as a therapeutic target by Lohinai et al., 2015 for Periodontal
Inflammation [56]. Here we listed 12 compounds showing good potency against our target
tabulated in Table 11. Four of the compounds with promising docking results are shown in
Fig 12.
Among the drug-like molecule ZINC13142972 (1-[(2S, 3S, 4S, 5R)-3,4-dihydroxy-5(hydroxymethyl) oxolan-2-yl]imidazo[1,2-b]pyrazole-7-carbonitrile) was predicted to show
good results against two of our targets NP_939302.1 (glpX, Fructose 1,6-bisphosphatase II)
and NP_939445.1 (DIP1084, Putative iron transport membrane protein, FecCD-family). It
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has been reported that at present 50% of drug molecules are either from natural source or their
derivatives [57]. Interestingly, the compounds from second library of ZINC (Natural Product)
showed better energy scores among all the libraries. Furthermore, from the library of natural
compounds (28 molecules), Jacarandic Acid and Rhein were identified as the top ranked molecules and in silico analysis of the library (derivatives of diterpenoid isosteviol) suggest that
compounds 16-hydroxyisosteviol, 16-hydrazonisosteviol, 17-hydroxyisosteviol, 16–17 dihydroxyisosteviol and 16-oxime, 17-hydroxyisosteviol were top ranked molecules, however, with
much higher energy scores (less negative) than the top compounds from the ZINC libraries
(ZINC drug-like molecules, ZINC Natural Product).

Conclusion
We utilized a bioinformatics pipeline for determining the conserved proteome of 13 strains of
C. diphtheriae, and subsequently exploit 3D structural information, resulting in a small set of
prioritized putative drug/vaccine targets, of which eight proteins are pathogen-essential, nonhost homologous and 15 are pathogen-essential, host-homologs. After a detailed structural
comparison between host and pathogen proteins, we suggest that eight of the non -host homologs could be considered for antimicrobial chemotherapy in future studies on anti-diphtheriae
drugs and vaccines. Moreover, the strategy described herein is of general nature and can also
be employed to other pathogenic microorganisms.
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